Found 7 results
Author [ Keyword(Asc)] Title Type Year
Filters: Author is Myzak, Melinda C and First Letter Of Keyword is P  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Proteins
Myzak MC, Dashwood RH.  2006.  Chemoprotection by sulforaphane: keep one eye beyond Keap1.. Cancer Lett. 233(2):208-18.
Protein Processing, Post-Translational
Myzak MC, W Dashwood M, Orner GA, Ho E, Dashwood RH.  2006.  Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice.. FASEB J. 20(3):506-8.
Prostatic Neoplasms
Myzak MC, Hardin K, Wang R, Dashwood RH, Ho E.  2006.  Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells.. Carcinogenesis. 27(4):811-9.
Prostatic Hyperplasia
Myzak MC, Hardin K, Wang R, Dashwood RH, Ho E.  2006.  Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells.. Carcinogenesis. 27(4):811-9.
Prostate
Myzak MC, Hardin K, Wang R, Dashwood RH, Ho E.  2006.  Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells.. Carcinogenesis. 27(4):811-9.
Phosphorylation
Al-Fageeh M, Li Q, W Dashwood M, Myzak MC, Dashwood RH.  2004.  Phosphorylation and ubiquitination of oncogenic mutants of beta-catenin containing substitutions at Asp32.. Oncogene. 23(28):4839-46.
Peroxidase
Myzak MC, Carr AC.  2002.  Myeloperoxidase-dependent caspase-3 activation and apoptosis in HL-60 cells: protection by the antioxidants ascorbate and (dihydro)lipoic acid.. Redox Rep. 7(1):47-53.